Search

everythinglearnresearchcommunity

for

Search:↓

Significant progress has been made in treating skin, hair, and nail disorders in people with skin of color, but disparities still exist.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

People with Type 2 Diabetes are more likely to have a mite infestation called Demodex folliculorum.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

A reliable method was developed to detect hair growth compounds in products, ensuring safety and compliance.

New treatments for alopecia show promise in restoring hair growth by targeting immune and hormonal factors.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

The guideline recommends personalized treatment for alopecia areata, including new oral medications and psychological support.

Combining different drugs can improve hair loss treatment.

A personalized treatment combining traditional and new therapies may improve hair loss outcomes in alopecia areata.

Hair loss negatively impacts quality of life, and psychological support can help.

Primary cicatricial alopecia is linked to various health issues, indicating broader systemic problems.

Cosmeceuticals like sunscreens may trigger frontal fibrosing alopecia, but more research is needed.

Phenobarbital-loaded chitosan nanoparticles are promising for preventing hair loss from chemotherapy.

Metal nanoparticles show promise for treating hair loss but need more research to ensure safety.

New hair regrowth therapies show promise but need more research.

New treatments are needed for non-scarring alopecia due to current limitations.

New treatments for hair loss show promise with advanced therapies and better targeting.

Non-laser devices show promise in treating hair issues, but more research is needed.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Alopecia areata causes significant emotional and social challenges, especially with more hair loss.

Wigs help improve self-esteem and quality of life for people with hair loss from alopecia areata.

Spanlastic-laden nanogel could be a better way to deliver hair growth medication through the skin for treating hair loss.

A woman's hair loss was misdiagnosed as alopecia areata but was actually lichen planopilaris, needing immediate and ongoing treatment.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.